Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients

Effect of Polydextrose Intake on Constipation in Japanese Dialysis Patients: A Triple-Blind, Randomized, Controlled Trial

“…In a United States study, a statistically significant difference was observed in the dietary fiber content between maintenance HD patients and non-dialysis control subjects (1266 g/d vs. 18611 g/d, p50.02) (22). Moreover, intake of total dietary fiber per day has been reported to be 5.962.7 g in Japanese HD patients (23). These data indicate that maintenance HD patients had significantly lower intakes of dietary fiber when compared with individuals not receiving dialysis.…”

Lubiprostone, a novel laxative, might improve hyperphosphatemia without water dilution

“…Hemodialysis patients have a high prevalence of constipation due to dietary restriction, fluid restriction, and use of phosphate binders [1]. It has been reported that constipation is associated with an increased risk of death from cardiovascular disease (CVD) [6], suggesting the importance of bowel control in dialysis patients, who have a high risk of death from CVD [7].…”

“…Hemodialysis patients have a higher prevalence of constipation than patients with normal renal function, due to dietary restriction, fluid restriction, and use of phosphate and/or potassium binders [1]. Given the risk of hypermagnesemia due to the use of magnesium oxide preparations, which are saline laxatives [2], hemodialysis patients often use sennosides, which are stimulant laxatives.…”

Functional bowel disorders and associated risk factors in hemodialysis patients in Turkey

“…A10: Was there reduction in or relief from pain or discomfort around your stomach or belly on defecation in the last 1 year? A11: Did you defecate more frequently in the last 1 year since your pain 1. The presence of abdominal discomfort or pain that is relieved with defecation and/or associated with a change in frequency of stools and/or associated with a change in the form (appearance) of stools.…”

“…Gastrointestinal symptoms (GISs) in patients with endstage renal disease (ESRD) show changes depending on uremia, the treatment model, changes in diet, and drugs used (1) and are also seen in 77-79% of these patients (2). GISs show differences depending on the stage of chronic kidney disease (CKD) and type of renal replacement therapy.…”